CFO
Callan Family Office Portfolio holdings
AUM
$3.17B
This Quarter Return
+6.16%
1 Year Return
+21.62%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$412M
AUM Growth
+$412M
(+33%)
Cap. Flow
+$85.6M
Cap. Flow
% of AUM
20.78%
Top 10 Holdings %
Top 10 Hldgs %
57.33%
Holding
160
New
58
Increased
65
Reduced
17
Closed
7
Top Buys
| 1 |
iShares MSCI EAFE ETF
EFA
|
$16M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$10.3M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
$5.48M |
| 4 |
Wells Fargo
WFC
|
$4.75M |
| 5 |
Microsoft
MSFT
|
$4.27M |
Top Sells
| 1 |
Vanguard Large-Cap ETF
VV
|
$15M |
| 2 |
Caterpillar
CAT
|
$3.21M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
$2.83M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
$884K |
| 5 |
Vanguard Mid-Cap ETF
VO
|
$508K |
Sector Composition
| 1 | Technology | 5.19% |
| 2 | Financials | 4.4% |
| 3 | Healthcare | 3.71% |
| 4 | Industrials | 2.12% |
| 5 | Communication Services | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $1.18M | 0.29% | 24,274 -10,375 | -30% | -$506K |
|
52
Goldman Sachs
GS
$226B
| $1.18M | 0.29% | +3,605 | New | +$1.18M |
|
53
iShares Russell Mid-Cap Value ETF
IWS
$14.1B
| $1.18M | 0.29% | 11,091 +5,009 | +82% | +$532K |
|
54
Gilead Sciences
GILD
$140B
| $1.14M | 0.28% | +13,778 | New | +$1.14M |
|
55
Chevron
CVX
$324B
| $1.13M | 0.27% | 6,915 +4,005 | +138% | +$653K |
|
56
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$1.7B
| $1.13M | 0.27% | 54,242 | – | – |
|
57
Johnson Controls International
JCI
$69.9B
| $1.07M | 0.26% | +17,745 | New | +$1.07M |
|
58
First Trust NASDAQ Cybersecurity ETF
CIBR
$10.5B
| $1.05M | 0.25% | 24,500 | – | – |
|
59
iShares S&P 100 ETF
OEF
$22B
| $1.03M | 0.25% | +5,520 | New | +$1.03M |
|
60
Home Depot
HD
$405B
| $1.01M | 0.24% | 3,417 +2,063 | +152% | +$609K |
|
61
Charter Communications
CHTR
$36.3B
| $986K | 0.24% | +2,756 | New | +$986K |
|
62
PepsiCo
PEP
$204B
| $964K | 0.23% | 5,289 +1,974 | +60% | +$360K |
|
63
CVS Health
CVS
$92.8B
| $956K | 0.23% | 12,871 +10,701 | +493% | +$795K |
|
64
GSK
GSK
$79.9B
| $922K | 0.22% | +25,900 | New | +$922K |
|
65
Johnson & Johnson
JNJ
$427B
| $916K | 0.22% | 5,909 +1,495 | +34% | +$232K |
|
66
GE Aerospace
GE
$292B
| $892K | 0.22% | +9,333 | New | +$892K |
|
67
Eaton
ETN
$136B
| $887K | 0.22% | 5,176 -97 | -2% | -$16.6K |
|
68
Bank of New York Mellon
BK
$74.5B
| $884K | 0.21% | +19,447 | New | +$884K |
|
69
Novartis
NVS
$245B
| $884K | 0.21% | +9,605 | New | +$884K |
|
70
Procter & Gamble
PG
$368B
| $862K | 0.21% | 5,794 +1,133 | +24% | +$168K |
|
71
Target
TGT
$43.6B
| $850K | 0.21% | 5,130 -28 | -0.5% | -$4.64K |
|
72
MetLife
MET
$54.1B
| $843K | 0.2% | +14,542 | New | +$843K |
|
73
Merck
MRK
$210B
| $811K | 0.2% | 7,619 +2,532 | +50% | +$269K |
|
74
ConocoPhillips
COP
$124B
| $804K | 0.2% | +8,104 | New | +$804K |
|
75
Booking.com
BKNG
$181B
| $748K | 0.18% | +282 | New | +$748K |
|